Danilo Tagle,
Associate Director,
NIH/NCATS
Dr. Danilo Tagle is Associate Director for Special Initiatives at the National Center for Advancing Translational Sciences (NCATS). He leads and manages the 1) NIH Microphysiological Systems program, and 2) Extracellular RNA Communication program, which involves coordination with other NIH institutes and centers, including the NIH Common Fund, as well as partnerships with other government agencies, such FDA and DARPA, and the private sector. Prior to joining NCATS, Dr. Tagle was a Program Director for Neurogenetics at the National Institute of Neurological Disorders and Stroke (NINDS)where he was involved in developing programs in genomics–based approaches for basic and translational research in inherited brain disorders. Dr. Tagle obtained his Ph.D. in Molecular Biology and Genetics from Wayne State University in 1990. He was an NIH NRSA postdoctoral fellow in Human Genetics at the laboratory of Dr. Francis S. Collins at the University of Michigan. Prior to joining NINDS in 2001, Dr. Tagle was an Investigator and Section Head of Molecular Neurogenetics at the National Human Genome Research Institute(NHGRI) since 1993, and has been involved in the positional cloning of genes for Huntington’s disease, ataxia-telangiectasia and Niemann-Pick type C disease. In addition to being Associate Director for Special Initiatives, Dr. Tagle recently served as Acting Director for the NCATS Office of Grants Management and Scientific Review, and currently serves as Executive Secretary to the NCATS Advisory Council, as well as the Cures Acceleration Network Review Board.
|
|
|